Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy | 53 | 2024 | 3290 | 3.840 |
Why?
|
Seizures | 40 | 2024 | 2956 | 3.030 |
Why?
|
Electroencephalography | 69 | 2024 | 6224 | 2.990 |
Why?
|
Anticonvulsants | 31 | 2023 | 1906 | 2.920 |
Why?
|
Epilepsy, Temporal Lobe | 19 | 2022 | 389 | 2.510 |
Why?
|
Status Epilepticus | 14 | 2021 | 460 | 2.230 |
Why?
|
Epilepsy, Generalized | 6 | 2023 | 178 | 2.140 |
Why?
|
Epilepsies, Partial | 12 | 2023 | 431 | 1.860 |
Why?
|
Foramen Ovale | 3 | 2024 | 17 | 1.490 |
Why?
|
Electric Stimulation Therapy | 9 | 2021 | 627 | 1.370 |
Why?
|
Hippocampus | 16 | 2022 | 3763 | 0.930 |
Why?
|
Brain | 32 | 2024 | 27103 | 0.720 |
Why?
|
Neurocysticercosis | 1 | 2021 | 91 | 0.700 |
Why?
|
Virus Inactivation | 1 | 2020 | 20 | 0.700 |
Why?
|
Enterovirus B, Human | 1 | 2020 | 47 | 0.700 |
Why?
|
Brain Waves | 5 | 2018 | 408 | 0.680 |
Why?
|
Anterior Thalamic Nuclei | 1 | 2019 | 27 | 0.670 |
Why?
|
Serum Albumin, Bovine | 1 | 2020 | 322 | 0.650 |
Why?
|
Implantable Neurostimulators | 4 | 2021 | 75 | 0.620 |
Why?
|
Atrophy | 4 | 2016 | 1632 | 0.610 |
Why?
|
Charcoal | 2 | 2017 | 67 | 0.610 |
Why?
|
Sewage | 1 | 2017 | 42 | 0.580 |
Why?
|
Temporal Lobe | 6 | 2015 | 1695 | 0.530 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2016 | 93 | 0.520 |
Why?
|
Malformations of Cortical Development | 2 | 2023 | 176 | 0.520 |
Why?
|
Agriculture | 1 | 2017 | 191 | 0.520 |
Why?
|
Electrodes, Implanted | 5 | 2024 | 840 | 0.510 |
Why?
|
Anterior Temporal Lobectomy | 4 | 2022 | 46 | 0.490 |
Why?
|
Chlorophyta | 1 | 2014 | 16 | 0.480 |
Why?
|
Perceptual Disorders | 1 | 2016 | 198 | 0.480 |
Why?
|
Cerebral Cortex | 11 | 2017 | 5776 | 0.470 |
Why?
|
Aquaculture | 1 | 2014 | 29 | 0.470 |
Why?
|
Fresh Water | 1 | 2014 | 82 | 0.470 |
Why?
|
DNA Fragmentation | 5 | 2005 | 237 | 0.460 |
Why?
|
Seaweed | 1 | 2014 | 28 | 0.460 |
Why?
|
Radiosurgery | 7 | 2019 | 1342 | 0.460 |
Why?
|
Biomass | 1 | 2014 | 137 | 0.450 |
Why?
|
GABA Agonists | 1 | 2013 | 105 | 0.430 |
Why?
|
Frontal Lobe | 1 | 2019 | 1420 | 0.420 |
Why?
|
Pilocarpine | 2 | 2009 | 64 | 0.420 |
Why?
|
Triazines | 1 | 2014 | 311 | 0.400 |
Why?
|
Kainic Acid | 4 | 2005 | 203 | 0.390 |
Why?
|
Quality of Life | 13 | 2023 | 13355 | 0.390 |
Why?
|
Electrodes | 4 | 2024 | 615 | 0.380 |
Why?
|
Drug Resistance | 4 | 2013 | 1597 | 0.380 |
Why?
|
Caregivers | 2 | 2013 | 2235 | 0.370 |
Why?
|
Epilepsy, Absence | 1 | 2011 | 49 | 0.370 |
Why?
|
Behavior, Animal | 5 | 2009 | 1878 | 0.360 |
Why?
|
Propofol | 2 | 2020 | 603 | 0.340 |
Why?
|
Humans | 138 | 2024 | 761326 | 0.340 |
Why?
|
Adult | 70 | 2024 | 221122 | 0.340 |
Why?
|
Piracetam | 1 | 2009 | 88 | 0.330 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 3687 | 0.330 |
Why?
|
Societies, Medical | 2 | 2015 | 3905 | 0.330 |
Why?
|
Progesterone | 1 | 2013 | 742 | 0.320 |
Why?
|
Male | 94 | 2024 | 360621 | 0.320 |
Why?
|
Astrocytoma | 1 | 2013 | 775 | 0.310 |
Why?
|
Pseudopregnancy | 1 | 2008 | 10 | 0.310 |
Why?
|
Hypoxia, Brain | 1 | 2009 | 138 | 0.300 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2020 | 1496 | 0.300 |
Why?
|
Glioblastoma | 1 | 2023 | 3482 | 0.300 |
Why?
|
Subacute Sclerosing Panencephalitis | 1 | 2007 | 26 | 0.300 |
Why?
|
Water | 1 | 2014 | 1410 | 0.300 |
Why?
|
Encephalitis | 2 | 2008 | 438 | 0.300 |
Why?
|
Practice Guidelines as Topic | 5 | 2016 | 7389 | 0.290 |
Why?
|
Limbic Encephalitis | 1 | 2007 | 36 | 0.290 |
Why?
|
Magnetic Resonance Imaging | 27 | 2021 | 36430 | 0.290 |
Why?
|
Hyperprolactinemia | 1 | 2008 | 124 | 0.280 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18234 | 0.260 |
Why?
|
Brain Diseases | 5 | 2018 | 1545 | 0.260 |
Why?
|
Middle Aged | 53 | 2024 | 220774 | 0.260 |
Why?
|
Neuroprotective Agents | 2 | 2002 | 957 | 0.260 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2005 | 48 | 0.260 |
Why?
|
Female | 77 | 2024 | 392485 | 0.260 |
Why?
|
Delusions | 1 | 2008 | 298 | 0.260 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2007 | 170 | 0.250 |
Why?
|
Neurosurgical Procedures | 4 | 2011 | 2071 | 0.240 |
Why?
|
Brain Damage, Chronic | 1 | 2005 | 267 | 0.240 |
Why?
|
Phosphorus | 2 | 2017 | 336 | 0.240 |
Why?
|
Radiation, Ionizing | 1 | 2005 | 251 | 0.230 |
Why?
|
Carbamazepine | 2 | 2023 | 224 | 0.230 |
Why?
|
Blood Chemical Analysis | 2 | 2021 | 437 | 0.230 |
Why?
|
Rats, Sprague-Dawley | 12 | 2009 | 8166 | 0.230 |
Why?
|
Sleep Apnea Syndromes | 1 | 2012 | 975 | 0.230 |
Why?
|
Sclerosis | 4 | 2018 | 210 | 0.220 |
Why?
|
Rats | 24 | 2009 | 23729 | 0.220 |
Why?
|
Tidal Waves | 1 | 2023 | 3 | 0.220 |
Why?
|
Young Adult | 30 | 2024 | 59196 | 0.220 |
Why?
|
Excitatory Amino Acid Agonists | 2 | 2005 | 144 | 0.220 |
Why?
|
Scalp | 3 | 2022 | 389 | 0.220 |
Why?
|
Retrospective Studies | 28 | 2024 | 80575 | 0.210 |
Why?
|
Clinical Trials as Topic | 6 | 2018 | 7999 | 0.210 |
Why?
|
Functional Laterality | 9 | 2018 | 2256 | 0.210 |
Why?
|
Perforant Pathway | 1 | 2002 | 24 | 0.200 |
Why?
|
Nerve Growth Factors | 1 | 2005 | 563 | 0.200 |
Why?
|
Alzheimer Disease | 3 | 2020 | 8592 | 0.200 |
Why?
|
Spinal Diseases | 1 | 2007 | 564 | 0.200 |
Why?
|
Memory Disorders | 4 | 2020 | 1198 | 0.190 |
Why?
|
Stereotaxic Techniques | 1 | 2024 | 555 | 0.190 |
Why?
|
Diagnosis, Differential | 6 | 2021 | 12972 | 0.190 |
Why?
|
Parasitic Diseases | 1 | 2021 | 76 | 0.190 |
Why?
|
Emotions | 1 | 2013 | 2738 | 0.190 |
Why?
|
Epilepsy, Complex Partial | 2 | 2017 | 56 | 0.190 |
Why?
|
Drugs, Investigational | 2 | 2013 | 212 | 0.190 |
Why?
|
Critical Care | 3 | 2020 | 2697 | 0.190 |
Why?
|
Sleep | 1 | 2017 | 4765 | 0.190 |
Why?
|
Fatal Outcome | 4 | 2016 | 1833 | 0.190 |
Why?
|
Medical Records | 2 | 2017 | 1408 | 0.190 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3460 | 0.180 |
Why?
|
Neurons | 9 | 2013 | 9458 | 0.180 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1122 | 0.180 |
Why?
|
Nerve Degeneration | 3 | 2013 | 748 | 0.180 |
Why?
|
Positron-Emission Tomography | 6 | 2019 | 6478 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 476 | 0.180 |
Why?
|
Aged | 32 | 2021 | 169179 | 0.170 |
Why?
|
Memory | 4 | 2018 | 2187 | 0.170 |
Why?
|
Adolescent | 24 | 2024 | 88305 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2002 | 1246 | 0.170 |
Why?
|
Monitoring, Physiologic | 3 | 2018 | 1780 | 0.160 |
Why?
|
Aphasia | 2 | 2013 | 192 | 0.160 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 1066 | 0.160 |
Why?
|
Depressive Disorder | 2 | 2020 | 3728 | 0.160 |
Why?
|
Animals | 42 | 2024 | 168388 | 0.160 |
Why?
|
Deep Brain Stimulation | 2 | 2017 | 832 | 0.160 |
Why?
|
Genes | 3 | 1992 | 1844 | 0.160 |
Why?
|
Suicide | 3 | 2022 | 1598 | 0.160 |
Why?
|
Low Back Pain | 1 | 2007 | 984 | 0.150 |
Why?
|
Immunoblotting | 1 | 2021 | 1647 | 0.150 |
Why?
|
Corpus Callosum | 1 | 2003 | 751 | 0.150 |
Why?
|
Factitious Disorders | 1 | 1998 | 39 | 0.150 |
Why?
|
Gene Expression Regulation | 9 | 2010 | 11900 | 0.150 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.150 |
Why?
|
Memantine | 1 | 2018 | 108 | 0.150 |
Why?
|
Treatment Outcome | 16 | 2021 | 64645 | 0.150 |
Why?
|
Glucocorticoids | 1 | 2007 | 2163 | 0.140 |
Why?
|
Gyrus Cinguli | 2 | 2015 | 1115 | 0.140 |
Why?
|
Waste Management | 1 | 2017 | 19 | 0.140 |
Why?
|
Brain Injuries | 4 | 2009 | 2053 | 0.140 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2018 | 246 | 0.140 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2018 | 448 | 0.140 |
Why?
|
Consciousness Disorders | 1 | 2021 | 441 | 0.140 |
Why?
|
Postoperative Complications | 5 | 2018 | 15647 | 0.140 |
Why?
|
Capsid Proteins | 1 | 2020 | 467 | 0.140 |
Why?
|
Soil | 1 | 2017 | 114 | 0.140 |
Why?
|
Drug Industry | 1 | 2023 | 788 | 0.130 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2020 | 339 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2019 | 2009 | 0.130 |
Why?
|
Convulsants | 3 | 2005 | 70 | 0.130 |
Why?
|
RNA, Messenger | 10 | 2010 | 12787 | 0.130 |
Why?
|
Drug Discovery | 2 | 2013 | 1054 | 0.130 |
Why?
|
Magnetoencephalography | 3 | 2010 | 636 | 0.130 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2007 | 2152 | 0.120 |
Why?
|
Nerve Net | 3 | 2018 | 2288 | 0.120 |
Why?
|
Rest | 1 | 2020 | 919 | 0.120 |
Why?
|
Coma | 1 | 2018 | 484 | 0.120 |
Why?
|
Brain Mapping | 7 | 2017 | 6626 | 0.120 |
Why?
|
Follow-Up Studies | 11 | 2020 | 39108 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2004 | 2790 | 0.120 |
Why?
|
Neuropsychological Tests | 5 | 2017 | 7045 | 0.120 |
Why?
|
Perciformes | 1 | 2014 | 24 | 0.120 |
Why?
|
Antipsychotic Agents | 1 | 2008 | 3067 | 0.120 |
Why?
|
Receptors, Dopamine | 2 | 1992 | 296 | 0.120 |
Why?
|
Monitoring, Intraoperative | 2 | 2012 | 941 | 0.120 |
Why?
|
Vision Disorders | 2 | 2018 | 1088 | 0.120 |
Why?
|
Brain Neoplasms | 2 | 2013 | 9030 | 0.120 |
Why?
|
Infectious Disease Incubation Period | 1 | 2014 | 16 | 0.120 |
Why?
|
Biodegradation, Environmental | 1 | 2014 | 216 | 0.110 |
Why?
|
Sleep Stages | 1 | 2018 | 693 | 0.110 |
Why?
|
Transcription Factors | 11 | 1994 | 12122 | 0.110 |
Why?
|
Videotape Recording | 2 | 2007 | 337 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2013 | 1337 | 0.110 |
Why?
|
Rabies | 1 | 2014 | 54 | 0.110 |
Why?
|
Synapses | 5 | 1991 | 1769 | 0.110 |
Why?
|
Pulvinar | 1 | 2013 | 23 | 0.110 |
Why?
|
Neurosurgery | 2 | 2011 | 679 | 0.110 |
Why?
|
Brain Ischemia | 2 | 2018 | 3048 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2005 | 472 | 0.110 |
Why?
|
Neocortex | 1 | 2017 | 417 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2018 | 983 | 0.110 |
Why?
|
Dominance, Cerebral | 2 | 2017 | 623 | 0.110 |
Why?
|
Critical Illness | 3 | 2022 | 2722 | 0.110 |
Why?
|
Cerebral Ventricles | 2 | 2001 | 542 | 0.110 |
Why?
|
Nitrogen | 1 | 2014 | 348 | 0.100 |
Why?
|
Psychotic Disorders | 1 | 2008 | 3223 | 0.100 |
Why?
|
Antibodies, Antinuclear | 1 | 2014 | 344 | 0.100 |
Why?
|
Metals | 1 | 2017 | 718 | 0.100 |
Why?
|
Semantics | 1 | 2016 | 601 | 0.100 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2015 | 578 | 0.100 |
Why?
|
Fisheries | 1 | 2012 | 50 | 0.100 |
Why?
|
Anthozoa | 1 | 2012 | 66 | 0.100 |
Why?
|
Immediate-Early Proteins | 5 | 1993 | 449 | 0.100 |
Why?
|
Plant Proteins | 1 | 2014 | 369 | 0.100 |
Why?
|
Visual Perception | 2 | 2016 | 1385 | 0.100 |
Why?
|
Prognosis | 7 | 2020 | 29588 | 0.100 |
Why?
|
Electroshock | 2 | 1992 | 121 | 0.100 |
Why?
|
Secondary Prevention | 2 | 2008 | 1474 | 0.100 |
Why?
|
Myoclonic Epilepsies, Progressive | 1 | 2011 | 13 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1935 | 0.100 |
Why?
|
Hypesthesia | 1 | 2011 | 107 | 0.090 |
Why?
|
Receptors, Scavenger | 1 | 2011 | 123 | 0.090 |
Why?
|
Confusion | 1 | 2013 | 278 | 0.090 |
Why?
|
Algorithms | 4 | 2019 | 14025 | 0.090 |
Why?
|
Chorea | 1 | 2011 | 79 | 0.090 |
Why?
|
Postoperative Period | 2 | 2013 | 1813 | 0.090 |
Why?
|
Carbon | 1 | 2014 | 665 | 0.090 |
Why?
|
Snoring | 1 | 2012 | 209 | 0.090 |
Why?
|
Paresthesia | 1 | 2011 | 162 | 0.090 |
Why?
|
Monoacylglycerol Lipases | 1 | 2010 | 36 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 934 | 0.090 |
Why?
|
Conservation of Natural Resources | 1 | 2012 | 211 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2013 | 3577 | 0.090 |
Why?
|
Rats, Inbred Strains | 8 | 1992 | 2090 | 0.090 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2018 | 1033 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2018 | 882 | 0.090 |
Why?
|
Social Adjustment | 1 | 2012 | 632 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2650 | 0.090 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2011 | 134 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3873 | 0.090 |
Why?
|
Perception | 1 | 2016 | 1197 | 0.080 |
Why?
|
Biological Transport | 1 | 2014 | 2090 | 0.080 |
Why?
|
Endocannabinoids | 1 | 2010 | 111 | 0.080 |
Why?
|
Age of Onset | 2 | 2024 | 3303 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2498 | 0.080 |
Why?
|
Abnormalities, Multiple | 3 | 2010 | 1424 | 0.080 |
Why?
|
Fishes | 1 | 2012 | 603 | 0.080 |
Why?
|
Epilepsy, Frontal Lobe | 1 | 2009 | 24 | 0.080 |
Why?
|
Receptors, Neurotransmitter | 1 | 1989 | 174 | 0.080 |
Why?
|
Treatment Failure | 2 | 2013 | 2642 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2019 | 58946 | 0.080 |
Why?
|
Evoked Potentials, Motor | 1 | 2012 | 464 | 0.080 |
Why?
|
Demyelinating Diseases | 1 | 2011 | 351 | 0.080 |
Why?
|
Databases, Bibliographic | 1 | 2009 | 130 | 0.080 |
Why?
|
Heart Arrest | 1 | 2018 | 1514 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2018 | 1998 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2018 | 1469 | 0.080 |
Why?
|
Metabolism, Inborn Errors | 1 | 2010 | 286 | 0.080 |
Why?
|
Volition | 1 | 2008 | 62 | 0.080 |
Why?
|
Biological Clocks | 1 | 2010 | 318 | 0.070 |
Why?
|
Intelligence | 1 | 2012 | 924 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1379 | 0.070 |
Why?
|
Dementia | 2 | 2015 | 2686 | 0.070 |
Why?
|
Control Groups | 1 | 2007 | 104 | 0.070 |
Why?
|
Airway Obstruction | 1 | 2012 | 661 | 0.070 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 543 | 0.070 |
Why?
|
Diacylglycerol Kinase | 1 | 2007 | 48 | 0.070 |
Why?
|
Genes, Immediate-Early | 2 | 2000 | 102 | 0.070 |
Why?
|
Inclusion Bodies | 1 | 1988 | 281 | 0.070 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 1140 | 0.070 |
Why?
|
Disability Evaluation | 2 | 2016 | 1836 | 0.070 |
Why?
|
Bhutan | 2 | 2017 | 61 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4345 | 0.070 |
Why?
|
Disease Susceptibility | 2 | 2005 | 1791 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2578 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1669 | 0.070 |
Why?
|
Age Factors | 4 | 2016 | 18401 | 0.070 |
Why?
|
Circadian Rhythm | 1 | 2018 | 2574 | 0.070 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2007 | 75 | 0.070 |
Why?
|
Blood Cell Count | 1 | 2007 | 397 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2587 | 0.070 |
Why?
|
Radiation Injuries, Experimental | 1 | 2006 | 88 | 0.070 |
Why?
|
Vagus Nerve Stimulation | 1 | 2010 | 227 | 0.070 |
Why?
|
Phylogeny | 1 | 2014 | 2809 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1665 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2019 | 14597 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20092 | 0.060 |
Why?
|
Health Care Costs | 1 | 2019 | 3243 | 0.060 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2007 | 313 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10764 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2170 | 0.060 |
Why?
|
Hydrazones | 1 | 2006 | 103 | 0.060 |
Why?
|
Ribosome Inactivating Proteins, Type 1 | 1 | 2005 | 27 | 0.060 |
Why?
|
Basal Nucleus of Meynert | 1 | 2005 | 24 | 0.060 |
Why?
|
Complementary Therapies | 1 | 2010 | 486 | 0.060 |
Why?
|
Corpus Striatum | 1 | 1992 | 1235 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2020 | 3744 | 0.060 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 5 | 2018 | 894 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2014 | 6231 | 0.060 |
Why?
|
Software | 1 | 2020 | 4439 | 0.060 |
Why?
|
Time Factors | 9 | 2018 | 39974 | 0.060 |
Why?
|
Silver Staining | 1 | 2005 | 62 | 0.060 |
Why?
|
Amnesia | 1 | 1987 | 255 | 0.060 |
Why?
|
Epilepsy, Tonic-Clonic | 2 | 2017 | 54 | 0.060 |
Why?
|
Polysomnography | 1 | 2012 | 1847 | 0.060 |
Why?
|
Myositis | 1 | 1988 | 271 | 0.060 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2005 | 68 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1403 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 191 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20555 | 0.060 |
Why?
|
Injections, Intraventricular | 1 | 2005 | 225 | 0.060 |
Why?
|
Injections, Epidural | 1 | 2007 | 201 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2011 | 710 | 0.060 |
Why?
|
Measles | 1 | 2007 | 183 | 0.060 |
Why?
|
Cholinergic Agents | 1 | 2005 | 96 | 0.060 |
Why?
|
Immunotoxins | 1 | 2005 | 175 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4760 | 0.060 |
Why?
|
Acute Disease | 2 | 2007 | 7238 | 0.060 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 3836 | 0.060 |
Why?
|
Pyridazines | 1 | 2006 | 202 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2007 | 544 | 0.060 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 2004 | 61 | 0.060 |
Why?
|
Ischemic Attack, Transient | 1 | 1990 | 879 | 0.060 |
Why?
|
Brain Edema | 1 | 2008 | 604 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 5 | 1992 | 1306 | 0.060 |
Why?
|
Muscular Diseases | 1 | 1988 | 553 | 0.060 |
Why?
|
Culture | 1 | 2008 | 623 | 0.060 |
Why?
|
Hypothermia, Induced | 1 | 2009 | 756 | 0.060 |
Why?
|
Random Allocation | 2 | 2007 | 2389 | 0.060 |
Why?
|
Movement Disorders | 1 | 2007 | 459 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2246 | 0.050 |
Why?
|
Electric Stimulation | 3 | 2002 | 1735 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16966 | 0.050 |
Why?
|
Autistic Disorder | 1 | 2012 | 1220 | 0.050 |
Why?
|
Genes, jun | 2 | 1993 | 69 | 0.050 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 539 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3249 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 641 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 687 | 0.050 |
Why?
|
Kindling, Neurologic | 2 | 2000 | 24 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2010 | 1178 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2017 | 5247 | 0.050 |
Why?
|
Recurrence | 3 | 2018 | 8470 | 0.050 |
Why?
|
Epilepsies, Myoclonic | 2 | 2013 | 85 | 0.050 |
Why?
|
Epilepsia Partialis Continua | 1 | 2021 | 18 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4812 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2163 | 0.050 |
Why?
|
Neurologic Examination | 1 | 2004 | 916 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2001 | 116 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 7954 | 0.050 |
Why?
|
Neurodegenerative Diseases | 1 | 2010 | 1086 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2005 | 11070 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4330 | 0.050 |
Why?
|
Translocation, Genetic | 1 | 2007 | 1393 | 0.050 |
Why?
|
Cell Count | 1 | 2005 | 1835 | 0.050 |
Why?
|
Mice | 7 | 2020 | 81474 | 0.050 |
Why?
|
Medicare | 1 | 2019 | 6758 | 0.050 |
Why?
|
Risk Factors | 5 | 2022 | 74152 | 0.050 |
Why?
|
Contractile Proteins | 1 | 2001 | 240 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6382 | 0.040 |
Why?
|
Child | 10 | 2014 | 80156 | 0.040 |
Why?
|
Menopause | 1 | 2008 | 1646 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2005 | 2678 | 0.040 |
Why?
|
Limbic System | 1 | 2002 | 419 | 0.040 |
Why?
|
Second Messenger Systems | 1 | 2000 | 202 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1968 | 0.040 |
Why?
|
DNA-Binding Proteins | 6 | 1994 | 9605 | 0.040 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2009 | 1472 | 0.040 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 1998 | 40 | 0.040 |
Why?
|
Nervous System | 1 | 2002 | 545 | 0.040 |
Why?
|
Autoantibodies | 1 | 2007 | 2123 | 0.040 |
Why?
|
Cohort Studies | 4 | 2021 | 41440 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4571 | 0.040 |
Why?
|
Cycloheximide | 2 | 1996 | 343 | 0.040 |
Why?
|
Syndrome | 3 | 2010 | 3268 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10551 | 0.040 |
Why?
|
Necrosis | 3 | 2006 | 1605 | 0.040 |
Why?
|
Pedigree | 3 | 2011 | 4589 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 1990 | 2656 | 0.040 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 50 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5428 | 0.040 |
Why?
|
Blotting, Northern | 4 | 1994 | 1545 | 0.040 |
Why?
|
Neuronal Plasticity | 3 | 2000 | 1435 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6815 | 0.040 |
Why?
|
Prospective Studies | 6 | 2020 | 54405 | 0.040 |
Why?
|
Emergencies | 1 | 2004 | 1217 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2023 | 5291 | 0.040 |
Why?
|
Preoperative Care | 2 | 2006 | 2242 | 0.040 |
Why?
|
X Chromosome | 1 | 2001 | 816 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2010 | 2897 | 0.040 |
Why?
|
Epilepsy, Partial, Motor | 1 | 2017 | 5 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 551 | 0.040 |
Why?
|
Lumbar Vertebrae | 1 | 2007 | 1879 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2011 | 17872 | 0.040 |
Why?
|
Cocaine | 2 | 1992 | 958 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2020 | 655 | 0.040 |
Why?
|
Migraine Disorders | 1 | 1990 | 1700 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2004 | 1189 | 0.040 |
Why?
|
Odds Ratio | 1 | 2009 | 9639 | 0.040 |
Why?
|
Cognition | 2 | 2018 | 6987 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8526 | 0.030 |
Why?
|
Verbal Learning | 1 | 2018 | 463 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14665 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 6178 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2018 | 411 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 956 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2004 | 1665 | 0.030 |
Why?
|
Zinc Fingers | 3 | 1994 | 579 | 0.030 |
Why?
|
Mutation | 2 | 2011 | 30044 | 0.030 |
Why?
|
Muscles | 2 | 1993 | 1575 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3768 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2001 | 1134 | 0.030 |
Why?
|
Gene Expression | 3 | 2000 | 7582 | 0.030 |
Why?
|
Neurobiology | 1 | 2016 | 137 | 0.030 |
Why?
|
Phenytoin | 1 | 2016 | 190 | 0.030 |
Why?
|
Proxy | 1 | 2016 | 151 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 705 | 0.030 |
Why?
|
Early Growth Response Protein 1 | 5 | 1993 | 133 | 0.030 |
Why?
|
Markov Chains | 1 | 2018 | 965 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 488 | 0.030 |
Why?
|
Genes, fos | 2 | 1992 | 175 | 0.030 |
Why?
|
Computers, Handheld | 1 | 2016 | 209 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 1998 | 796 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15262 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 822 | 0.030 |
Why?
|
Survival Analysis | 1 | 2007 | 10075 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2016 | 728 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2018 | 617 | 0.030 |
Why?
|
Carbachol | 1 | 1994 | 223 | 0.030 |
Why?
|
Amphetamine | 2 | 1992 | 224 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1571 | 0.030 |
Why?
|
Receptors, Dopamine D1 | 2 | 1992 | 293 | 0.030 |
Why?
|
Education | 1 | 2016 | 536 | 0.030 |
Why?
|
Depression | 1 | 2013 | 8122 | 0.030 |
Why?
|
Age Distribution | 1 | 1999 | 2880 | 0.030 |
Why?
|
Precipitating Factors | 1 | 2013 | 51 | 0.030 |
Why?
|
History, 20th Century | 1 | 2001 | 2770 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2605 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 3531 | 0.030 |
Why?
|
Muscle Denervation | 1 | 1993 | 60 | 0.030 |
Why?
|
Phosphorylation | 2 | 2002 | 8312 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2016 | 8997 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1668 | 0.030 |
Why?
|
Valproic Acid | 1 | 2016 | 443 | 0.030 |
Why?
|
Trout | 1 | 2012 | 20 | 0.030 |
Why?
|
Long-Term Care | 1 | 2017 | 633 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1486 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1444 | 0.030 |
Why?
|
Ecology | 1 | 2012 | 105 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2018 | 12329 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2014 | 451 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3330 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2018 | 1722 | 0.020 |
Why?
|
Visual Fields | 1 | 2018 | 1062 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2717 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1998 | 2114 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
Dopamine Agents | 1 | 1992 | 189 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2062 | 0.020 |
Why?
|
Prosencephalon | 1 | 1992 | 305 | 0.020 |
Why?
|
Gadolinium | 2 | 2006 | 960 | 0.020 |
Why?
|
N-Methylaspartate | 1 | 1990 | 231 | 0.020 |
Why?
|
Temperature | 1 | 2017 | 2229 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1025 | 0.020 |
Why?
|
Protons | 2 | 2006 | 1115 | 0.020 |
Why?
|
Pyramidal Tracts | 1 | 2012 | 252 | 0.020 |
Why?
|
United States | 4 | 2019 | 72317 | 0.020 |
Why?
|
Learning | 1 | 1999 | 1740 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22154 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13500 | 0.020 |
Why?
|
Executive Function | 1 | 2018 | 1389 | 0.020 |
Why?
|
Survivors | 1 | 2020 | 2370 | 0.020 |
Why?
|
Brazil | 1 | 2014 | 1230 | 0.020 |
Why?
|
Virulence Factors, Bordetella | 1 | 1989 | 154 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 1989 | 176 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 1993 | 616 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2625 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2006 | 4696 | 0.020 |
Why?
|
Cerebral Ventriculography | 1 | 1988 | 44 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 1990 | 321 | 0.020 |
Why?
|
Dogs | 1 | 2014 | 3839 | 0.020 |
Why?
|
Neurology | 1 | 2016 | 778 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 1992 | 665 | 0.020 |
Why?
|
Afferent Pathways | 1 | 1989 | 298 | 0.020 |
Why?
|
Ecosystem | 1 | 2012 | 490 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9180 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2011 | 862 | 0.020 |
Why?
|
Attention | 1 | 2018 | 2395 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10498 | 0.020 |
Why?
|
Psychosurgery | 1 | 1988 | 86 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1184 | 0.020 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1992 | 625 | 0.020 |
Why?
|
Language | 1 | 1996 | 1539 | 0.020 |
Why?
|
Phenotype | 3 | 2012 | 16603 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 1992 | 7597 | 0.020 |
Why?
|
Electromyography | 1 | 2012 | 1393 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 710 | 0.020 |
Why?
|
Brain Chemistry | 1 | 1990 | 959 | 0.020 |
Why?
|
Autoradiography | 3 | 1992 | 730 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9534 | 0.020 |
Why?
|
Pregnancy | 1 | 2007 | 29858 | 0.020 |
Why?
|
Neural Pathways | 1 | 2016 | 3057 | 0.020 |
Why?
|
Carotid Arteries | 1 | 1990 | 941 | 0.020 |
Why?
|
Infant | 2 | 2006 | 36202 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3204 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8632 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1988 | 2560 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3724 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2011 | 1399 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6236 | 0.020 |
Why?
|
Adenosine | 1 | 1989 | 805 | 0.010 |
Why?
|
Insurance, Health | 1 | 2016 | 2495 | 0.010 |
Why?
|
Neurofibromatosis 1 | 1 | 2009 | 560 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2358 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2011 | 2329 | 0.010 |
Why?
|
Health Status | 1 | 2016 | 4075 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10203 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13251 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15835 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7824 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6019 | 0.010 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2003 | 369 | 0.010 |
Why?
|
Child, Preschool | 3 | 2012 | 42251 | 0.010 |
Why?
|
Communication | 1 | 2016 | 3870 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15719 | 0.010 |
Why?
|
Benzoxazines | 1 | 2003 | 316 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 330 | 0.010 |
Why?
|
Quality Improvement | 1 | 2016 | 3800 | 0.010 |
Why?
|
Calcium | 1 | 1994 | 5726 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2217 | 0.010 |
Why?
|
Oxazines | 1 | 2003 | 349 | 0.010 |
Why?
|
Coloring Agents | 1 | 2003 | 559 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2509 | 0.010 |
Why?
|
Electrophysiology | 1 | 2003 | 1262 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9605 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8223 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5492 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21336 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4227 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6966 | 0.010 |
Why?
|
Tetrodotoxin | 2 | 1991 | 246 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1994 | 4927 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26108 | 0.010 |
Why?
|
Kynurenic Acid | 1 | 1998 | 44 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4638 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1998 | 317 | 0.010 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2006 | 1958 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2820 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2011 | 3979 | 0.010 |
Why?
|
Biopsy | 1 | 1988 | 6768 | 0.010 |
Why?
|
Stroke | 1 | 2019 | 9749 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 12982 | 0.010 |
Why?
|
Hemodynamics | 1 | 2006 | 4167 | 0.010 |
Why?
|
Flavonoids | 1 | 1998 | 445 | 0.010 |
Why?
|
Ryanodine | 1 | 1994 | 46 | 0.010 |
Why?
|
Dantrolene | 1 | 1994 | 26 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 1999 | 761 | 0.010 |
Why?
|
Bungarotoxins | 1 | 1994 | 46 | 0.010 |
Why?
|
Calcimycin | 1 | 1994 | 213 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9414 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2004 | 2727 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 1993 | 67 | 0.010 |
Why?
|
Cell Death | 1 | 1998 | 1674 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1999 | 820 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23981 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4108 | 0.010 |
Why?
|
Reserpine | 1 | 1992 | 63 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 1993 | 6210 | 0.010 |
Why?
|
Receptors, Steroid | 1 | 1993 | 156 | 0.010 |
Why?
|
Early Growth Response Protein 2 | 1 | 1992 | 25 | 0.010 |
Why?
|
Apomorphine | 1 | 1992 | 149 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 1998 | 1172 | 0.010 |
Why?
|
DNA Probes | 1 | 1993 | 544 | 0.010 |
Why?
|
Oxidopamine | 1 | 1992 | 172 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2001 | 2637 | 0.010 |
Why?
|
Haloperidol | 1 | 1992 | 389 | 0.010 |
Why?
|
Benzazepines | 1 | 1992 | 310 | 0.010 |
Why?
|
Photic Stimulation | 1 | 1996 | 1985 | 0.010 |
Why?
|
Norepinephrine | 1 | 1992 | 897 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1992 | 586 | 0.010 |
Why?
|
Naltrexone | 1 | 1992 | 317 | 0.010 |
Why?
|
Motor Neurons | 1 | 1994 | 869 | 0.010 |
Why?
|
Cells, Cultured | 2 | 1998 | 18962 | 0.010 |
Why?
|
Mammals | 1 | 1994 | 1132 | 0.000 |
Why?
|
Picrotoxin | 1 | 1988 | 62 | 0.000 |
Why?
|
Pentylenetetrazole | 1 | 1988 | 71 | 0.000 |
Why?
|
In Situ Hybridization | 1 | 1992 | 1900 | 0.000 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1993 | 856 | 0.000 |
Why?
|
Sodium Channels | 1 | 1990 | 339 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 3710 | 0.000 |
Why?
|
Morphine | 1 | 1992 | 655 | 0.000 |
Why?
|
Serotonin | 1 | 1992 | 1041 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2006 | 26211 | 0.000 |
Why?
|
Kinetics | 1 | 1993 | 6374 | 0.000 |
Why?
|
GTP-Binding Proteins | 1 | 1989 | 950 | 0.000 |
Why?
|
Aging | 1 | 2001 | 8704 | 0.000 |
Why?
|
Models, Biological | 1 | 1998 | 9468 | 0.000 |
Why?
|
Visual Cortex | 1 | 1990 | 1107 | 0.000 |
Why?
|
Action Potentials | 1 | 1989 | 1834 | 0.000 |
Why?
|
Signal Transduction | 2 | 1998 | 23427 | 0.000 |
Why?
|
Cell Line | 1 | 1994 | 15599 | 0.000 |
Why?
|
Base Sequence | 1 | 1991 | 12449 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1991 | 17640 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 1990 | 4509 | 0.000 |
Why?
|